| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 33 | 2023 | 638 | 8.770 |
Why?
|
| CD4-Positive T-Lymphocytes | 22 | 2022 | 1052 | 4.420 |
Why?
|
| Cyclin-Dependent Kinase 9 | 17 | 2017 | 66 | 4.020 |
Why?
|
| Positive Transcriptional Elongation Factor B | 14 | 2019 | 37 | 3.400 |
Why?
|
| Host-Pathogen Interactions | 8 | 2019 | 304 | 3.100 |
Why?
|
| Cyclin T | 22 | 2019 | 42 | 2.900 |
Why?
|
| Virus Replication | 15 | 2019 | 781 | 2.740 |
Why?
|
| Virus Latency | 11 | 2022 | 79 | 2.590 |
Why?
|
| HIV Infections | 18 | 2023 | 2154 | 2.470 |
Why?
|
| Cyclins | 13 | 2015 | 467 | 2.460 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 9 | 2019 | 54 | 1.950 |
Why?
|
| Gene Expression Regulation, Viral | 10 | 2017 | 197 | 1.870 |
Why?
|
| RNA Polymerase II | 7 | 2018 | 184 | 1.590 |
Why?
|
| Anti-HIV Agents | 3 | 2021 | 354 | 1.490 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2019 | 196 | 1.300 |
Why?
|
| Macrophages | 9 | 2009 | 1351 | 1.200 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2019 | 18 | 1.190 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2018 | 320 | 1.170 |
Why?
|
| Virus Activation | 4 | 2022 | 236 | 1.130 |
Why?
|
| HIV Long Terminal Repeat | 8 | 2017 | 28 | 1.100 |
Why?
|
| Influenza A virus | 4 | 2019 | 166 | 0.970 |
Why?
|
| Monocytes | 6 | 2012 | 790 | 0.910 |
Why?
|
| MicroRNAs | 7 | 2015 | 2886 | 0.890 |
Why?
|
| Hydroxamic Acids | 2 | 2016 | 454 | 0.830 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 154 | 0.830 |
Why?
|
| RNA, Viral | 4 | 2019 | 727 | 0.800 |
Why?
|
| HIV | 3 | 2016 | 236 | 0.780 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2021 | 15 | 0.770 |
Why?
|
| RNA, Long Noncoding | 2 | 2018 | 618 | 0.750 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2023 | 368 | 0.750 |
Why?
|
| Gene Expression Regulation | 8 | 2019 | 4134 | 0.700 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 3341 | 0.680 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2012 | 223 | 0.650 |
Why?
|
| Gene Products, tat | 4 | 2016 | 65 | 0.640 |
Why?
|
| Jurkat Cells | 6 | 2021 | 320 | 0.630 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 149 | 0.620 |
Why?
|
| Immune Evasion | 1 | 2018 | 76 | 0.610 |
Why?
|
| Karyopherins | 2 | 2019 | 134 | 0.600 |
Why?
|
| Cell Line | 10 | 2019 | 5339 | 0.580 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 2196 | 0.550 |
Why?
|
| Transcription Factors | 8 | 2017 | 5437 | 0.550 |
Why?
|
| Phenylenediamines | 1 | 2016 | 22 | 0.530 |
Why?
|
| Depsipeptides | 1 | 2016 | 77 | 0.510 |
Why?
|
| PDZ Domains | 2 | 2012 | 15 | 0.510 |
Why?
|
| Leprosy | 1 | 2015 | 34 | 0.500 |
Why?
|
| HeLa Cells | 8 | 2012 | 1685 | 0.490 |
Why?
|
| Disulfiram | 1 | 2015 | 37 | 0.480 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 619 | 0.480 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2016 | 617 | 0.480 |
Why?
|
| Influenza in Birds | 2 | 2014 | 32 | 0.470 |
Why?
|
| Cell Nucleus | 4 | 2019 | 1712 | 0.470 |
Why?
|
| Cells, Cultured | 7 | 2021 | 5694 | 0.470 |
Why?
|
| Phosphorylation | 8 | 2016 | 4945 | 0.460 |
Why?
|
| Lymphocyte Activation | 5 | 2013 | 1723 | 0.450 |
Why?
|
| RNA, Small Nuclear | 4 | 2008 | 57 | 0.430 |
Why?
|
| RNA-Binding Proteins | 5 | 2010 | 1017 | 0.420 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 1899 | 0.420 |
Why?
|
| Humans | 54 | 2023 | 270462 | 0.400 |
Why?
|
| Interferon-beta | 1 | 2012 | 109 | 0.400 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 108 | 0.400 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2014 | 67 | 0.400 |
Why?
|
| Viral Proteins | 2 | 2011 | 491 | 0.390 |
Why?
|
| Tight Junctions | 1 | 2011 | 59 | 0.380 |
Why?
|
| Virus Integration | 3 | 2016 | 73 | 0.370 |
Why?
|
| Down-Regulation | 5 | 2018 | 2091 | 0.370 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2010 | 35 | 0.360 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 385 | 0.360 |
Why?
|
| Transcriptional Activation | 5 | 2019 | 1111 | 0.350 |
Why?
|
| Indoles | 1 | 2016 | 1028 | 0.350 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 3438 | 0.350 |
Why?
|
| Membrane Proteins | 2 | 2011 | 2929 | 0.350 |
Why?
|
| Pain | 2 | 2016 | 1698 | 0.350 |
Why?
|
| Calcium Signaling | 1 | 2012 | 282 | 0.350 |
Why?
|
| Viruses | 1 | 2011 | 156 | 0.340 |
Why?
|
| Antigens, Nuclear | 1 | 2010 | 126 | 0.340 |
Why?
|
| Cell Cycle | 1 | 2015 | 2137 | 0.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 1280 | 0.320 |
Why?
|
| Protein Binding | 5 | 2019 | 3485 | 0.310 |
Why?
|
| Neuralgia | 2 | 2023 | 265 | 0.310 |
Why?
|
| RNA, Messenger | 7 | 2011 | 6397 | 0.310 |
Why?
|
| Protein Transport | 3 | 2019 | 737 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 1469 | 0.300 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 327 | 0.300 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2005 | 157 | 0.290 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 230 | 0.290 |
Why?
|
| Phorbol Esters | 1 | 2006 | 42 | 0.280 |
Why?
|
| Genes, tat | 1 | 2006 | 15 | 0.280 |
Why?
|
| Cell Differentiation | 6 | 2009 | 4117 | 0.280 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2006 | 714 | 0.270 |
Why?
|
| Peptidoglycan | 1 | 2005 | 20 | 0.260 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 572 | 0.260 |
Why?
|
| Lipopolysaccharides | 2 | 2005 | 588 | 0.260 |
Why?
|
| Genes | 1 | 2006 | 607 | 0.250 |
Why?
|
| Apoptosis | 3 | 2022 | 7752 | 0.240 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 5141 | 0.240 |
Why?
|
| Gene Expression | 3 | 2012 | 3641 | 0.240 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 135 | 0.230 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 703 | 0.230 |
Why?
|
| Interleukin-10 | 1 | 2006 | 484 | 0.220 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2023 | 48 | 0.220 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2017 | 248 | 0.210 |
Why?
|
| DNA | 3 | 2006 | 3049 | 0.210 |
Why?
|
| Lectins, C-Type | 1 | 2003 | 162 | 0.210 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 318 | 0.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 308 | 0.200 |
Why?
|
| DNA Repair | 1 | 2010 | 1910 | 0.200 |
Why?
|
| Proviruses | 2 | 2016 | 24 | 0.200 |
Why?
|
| Up-Regulation | 3 | 2017 | 2421 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3214 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2012 | 592 | 0.180 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 271 | 0.180 |
Why?
|
| Protein Phosphatase 2C | 2 | 2012 | 86 | 0.180 |
Why?
|
| RNA Transport | 1 | 2019 | 13 | 0.170 |
Why?
|
| Transfection | 3 | 2012 | 3118 | 0.170 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 904 | 0.170 |
Why?
|
| Isoquinolines | 1 | 2019 | 125 | 0.160 |
Why?
|
| In Vitro Techniques | 3 | 2006 | 1709 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2005 | 1622 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2021 | 329 | 0.160 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 126 | 0.150 |
Why?
|
| Polyadenylation | 1 | 2018 | 67 | 0.150 |
Why?
|
| Chemokine CCL19 | 1 | 2017 | 7 | 0.150 |
Why?
|
| Ionomycin | 1 | 2017 | 35 | 0.150 |
Why?
|
| RNA Interference | 2 | 2012 | 1386 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 269 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 1129 | 0.150 |
Why?
|
| Cytoplasm | 1 | 2019 | 701 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 5001 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 86 | 0.140 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 151 | 0.140 |
Why?
|
| Multienzyme Complexes | 2 | 2010 | 226 | 0.140 |
Why?
|
| Immunity, Innate | 2 | 2015 | 700 | 0.130 |
Why?
|
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2015 | 8 | 0.130 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 220 | 0.130 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 20 | 0.130 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2015 | 58 | 0.130 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2015 | 48 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 3943 | 0.130 |
Why?
|
| Recombinases | 1 | 2015 | 40 | 0.120 |
Why?
|
| Acetaldehyde Dehydrogenase Inhibitors | 1 | 2015 | 5 | 0.120 |
Why?
|
| Binding Sites | 2 | 2010 | 2255 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1296 | 0.120 |
Why?
|
| Animals | 10 | 2022 | 62012 | 0.120 |
Why?
|
| Drug Design | 1 | 2017 | 371 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2018 | 671 | 0.120 |
Why?
|
| Birds | 2 | 2014 | 98 | 0.110 |
Why?
|
| Base Sequence | 3 | 2006 | 5437 | 0.110 |
Why?
|
| Genes, Reporter | 2 | 2006 | 820 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1462 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 1006 | 0.110 |
Why?
|
| Analgesics | 1 | 2016 | 409 | 0.110 |
Why?
|
| Blotting, Northern | 2 | 2003 | 726 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 2115 | 0.110 |
Why?
|
| DEAD Box Protein 58 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Poly I-C | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2012 | 19 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2012 | 33 | 0.100 |
Why?
|
| Guanylate Kinases | 1 | 2012 | 27 | 0.100 |
Why?
|
| Texas | 1 | 2023 | 6433 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2016 | 1811 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 2474 | 0.100 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2011 | 10 | 0.100 |
Why?
|
| RNA Precursors | 1 | 2012 | 125 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 1641 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 84 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2018 | 759 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2018 | 1871 | 0.090 |
Why?
|
| Viral Matrix Proteins | 1 | 2011 | 181 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 233 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 313 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 256 | 0.090 |
Why?
|
| Ku Autoantigen | 1 | 2010 | 82 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 1426 | 0.090 |
Why?
|
| Benzamides | 1 | 2016 | 1878 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 271 | 0.090 |
Why?
|
| Threonine | 1 | 2010 | 163 | 0.090 |
Why?
|
| Histones | 1 | 2017 | 1512 | 0.090 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2009 | 26 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 57 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 232 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 252 | 0.080 |
Why?
|
| Flavonoids | 1 | 2010 | 201 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 340 | 0.080 |
Why?
|
| Casein Kinase I | 1 | 2008 | 22 | 0.080 |
Why?
|
| Lymphoma, T-Cell | 1 | 2011 | 366 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 338 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2010 | 848 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2008 | 356 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 768 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 339 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2011 | 1028 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2008 | 305 | 0.070 |
Why?
|
| Mutation | 3 | 2019 | 15901 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 480 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2390 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 1472 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 965 | 0.070 |
Why?
|
| Blood Cells | 1 | 2005 | 129 | 0.060 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2005 | 10 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2005 | 151 | 0.060 |
Why?
|
| CD52 Antigen | 1 | 2005 | 47 | 0.060 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2005 | 38 | 0.060 |
Why?
|
| Paxillin | 1 | 2005 | 32 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2005 | 99 | 0.060 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 17 | 0.060 |
Why?
|
| Gene Products, nef | 1 | 2004 | 14 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2010 | 1857 | 0.060 |
Why?
|
| Piperidines | 1 | 2010 | 1086 | 0.060 |
Why?
|
| RNA | 1 | 2009 | 1064 | 0.060 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2023 | 4 | 0.060 |
Why?
|
| Spleen | 1 | 2006 | 726 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 929 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2019 | 1255 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2003 | 48 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2003 | 351 | 0.060 |
Why?
|
| Solubility | 1 | 2003 | 247 | 0.060 |
Why?
|
| Leukocytes | 1 | 2005 | 422 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 936 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 262 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2023 | 83 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2005 | 277 | 0.050 |
Why?
|
| CD11c Antigen | 1 | 2002 | 56 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2016 | 3551 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 522 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 630 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 460 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2006 | 1164 | 0.050 |
Why?
|
| Mice | 4 | 2022 | 35574 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 512 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2003 | 877 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 779 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 249 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2020 | 49 | 0.050 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2022 | 288 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2022 | 712 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2005 | 1419 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1137 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2009 | 5725 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 92 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2004 | 1497 | 0.040 |
Why?
|
| Morphine | 1 | 2020 | 333 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2020 | 244 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1580 | 0.040 |
Why?
|
| Benzylidene Compounds | 1 | 2017 | 9 | 0.040 |
Why?
|
| Genome, Human | 1 | 2006 | 1885 | 0.040 |
Why?
|
| Piperidones | 1 | 2017 | 9 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 635 | 0.040 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 23 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 977 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 170 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 1016 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 282 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2002 | 1110 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 514 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6686 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5759 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 7382 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 624 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 910 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 2573 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2006 | 3072 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 214 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2022 | 1564 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4960 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 484 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2012 | 12098 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 4569 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 30976 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 3044 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 81851 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2516 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 1944 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 1050 | 0.020 |
Why?
|
| Male | 3 | 2020 | 128209 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 12996 | 0.020 |
Why?
|
| Research Design | 1 | 2016 | 1569 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1199 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 960 | 0.020 |
Why?
|
| Aged | 1 | 2013 | 73248 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 3294 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 7096 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 3586 | 0.020 |
Why?
|
| Middle Aged | 1 | 2013 | 90192 | 0.020 |
Why?
|
| Female | 3 | 2021 | 148723 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 9039 | 0.010 |
Why?
|
| Carcinoma | 1 | 2011 | 2609 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7234 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 10699 | 0.010 |
Why?
|